At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA) vaccine designed to help prevent triple-negative breast cancer (TNBC), ...

Trodelvy reduced risk of disease progression or death versus chemotherapy in patients with previously untreated metastatic triple-negative breast cancer. Treatment with Trodelvy (Sacituzumab govitecan ...

Marlon Wayans has encouraged fans to go and see his new horror film Him despite it receiving overwhelmingly negative reviews from critics. Wayans, who stars as the film’s antagonist, Isaiah White, has ...

Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Greenhouse gas emissions generated by humans may have “locked in” a climate pattern responsible for long-term megadrought across the U.S. West, a new study has found. Human-induced shifts to the ...

A negative mindset is known to trigger or heighten stress and anxiety — and new research has revealed other trickle-down effects on mental and physical health. Researchers from Amen Clinics, a ...

Following her celestial performance at the 2025 Roots Picnic in Philadelphia — where she captivated the crowd with a medley of her biggest hits like “Essence,” “Love Me JeJe,” and “Free Mind” — Tems ...

Already boasting a strong foothold in metastatic triple-negative breast cancer, Gilead Sciences’ Trodelvy has produced positive data that could make the antibody-drug conjugate part of a new ...

A phase II study to evaluate the safety and efficacy of BB-1701 in subjects with HER2 expression locally advanced/metastatic breast cancer previously treated with HER2-ADC containing TOP-I inhibitor.

Opthea's Phase 3 COAST trial for wet AMD failed its primary endpoint, raising concerns about the company's financial stability. Opthea Limited announced that its global Phase 3 trial, COAST, ...